The research behind the headlines New to GLP-1s? Start here
GLP-1 Roundup

A practical guide to the price of care.

Compare plans

Alan Health review

Alan Health, also known as Alan Meds, pairs compounded GLP-1 offers with a broad treatment catalog and dose-independent pricing claims.

We may earn a commission from partner links. Our reviews cover both partners and other providers. How we are funded

Michael Hayes’s take

The decision behind the offer.

I would put Alan on a comparison list for its stated flat pricing, but I would not buy from the headline alone. The promotion and inconsistent treatment language need a clear written explanation.

See the cost and care breakdown
In this review

What you are paying for

Comparing a prepaid promotion

Care
Online assessment and ongoing clinical messaging advertised
Medication
Compounded injection; confirm exact ingredient and preparation
Commitment
Two-month promotion paid upfront; three-business-day cancellation notice
Put the full year on paper

What stands out

  • Dose-independent pricing advertised
  • Published cancellation instructions

Where I would pause

  • Prepayment behind the monthly headline
  • Some landing-page language is inconsistent

The headline is a plan, not one monthly payment

Alan’s semaglutide page advertises $158 per month with a two-month upfront purchase. That is a different cash-flow decision from a single monthly charge. The catalog also lists tirzepatide and smaller-dose products; those are separate offers, not automatic substitutes for the pictured plan.

My starting point is the amount charged today. A discount can be worthwhile when you understand the commitment, but it loses its usefulness when the reader has to guess what happens after the first supply.

The medication description deserves a second look

One Alan landing page labels a semaglutide offer while using dose examples associated with tirzepatide; another passage reverses the stated uses of Ozempic and Wegovy. Those inconsistencies make that page a poor place to learn medication details. I would ask the clinician to confirm the exact ingredient, preparation and prescription before paying.

This is a criticism of the clarity of the advertising, not proof of a problem with a dispensed prescription. For a grounded comparison, our guide to reading GLP-1 trials explains why an ingredient name alone is not enough to transfer research results to another preparation.

Does this care model fit?

Review the current offer and the terms for your selected plan.

Explore Alan HealthA prescription requires an individual clinical assessment.

Cancellation needs advance notice

Alan’s FAQ asks for cancellation at least three business days before the next billing cycle, through support or the portal. Put the actual renewal date beside that instruction. A weekend can make three business days longer than the three calendar days a reader might assume.

I would request confirmation that renewal is stopped and separately ask what happens to a prescription already being prepared. Cancelling a future charge and recovering an earlier payment are different questions.

Where I would compare next

Compare Alan with Trimi for an explicit monthly-versus-prepaid comparison. If branded medication and insurance coordination are the priority, Ro is a different care model worth examining. Neither comparison establishes which treatment a clinician should prescribe.

Alan earns a closer look for a clearly stated commercial idea: keep the rate stable as a prescribed dose changes. It still needs a precise quote and cleaner medication communication to make that idea easy to trust.

A different fit might be better.

Compare the reason for choosing each service, not just the name on the offer.

Based on published provider information, not personal treatment. Our review standards explain how we assess offers. A clinician must determine individual treatment suitability.

Before you go

One more option to compare.

We may earn a commission from the partner below. It is a separate provider, and eligibility and treatment decisions require its own evaluation.

Explore partner Continue to your provider